In addition, PIM2 has been reported to directly phosphorylate TSC2 at Ser-1798, and to promote TSC2 suppression of mTOR-C1, suggesting a novel PIM2-TSC2-mTOR-C1 pathway driving MM proliferation 43. The gene discussed is PIM2; the disease is Miyoshi myopathy.